INTRODUCTION 47
Replication of HIV-1 is contingent upon a highly conserved catalytic event in 48 which retroviral integrase (IN) integrates the viral cDNA genome into the host 49 chromosome (2, 4). IN associates with and synapses the U3 and U5 termini of the linear 50 blunt-ended viral genome, forming a cytoplasmic nucleoprotein complex termed the 51 preintegration complex (PIC). IN, in an event termed 3'-OH processing, catalyzes the 52 removal of dinucleotides from the 3' end of each long terminal repeat (LTR) terminus. 53
Following nuclear localization, the PIC associates with host chromosomes and 54 coordinates a nucleophilic attack in which the 3' hydroxyl moieties of the CA nucleotide 55 attack the phosphodiester backbone of the host chromosomal DNA. This results in the 56 case of HIV-1, in a 5-bp stagger between the sites of covalency. The components of the 57 products (19). The gels were dried, exposed to a PhosphorImager screen and the DNA 138 products were quantified using a Storm 860 (Amersham Biosciences). 139
140
Analysis of native samples on agarose gels. 141
In addition to the analysis of deproteinized samples, aliquots were taken out of the 142 reaction mixture for native analysis prior to deproteinization. The reactions were stopped 143 by adding EDTA to 25 mM and the products were subjected to electrophoresis on 0.7% 144 agarose gels in TBE buffer at 4 ºC (16, 19, 20) . 
Synthesis and visualization of intermediate and terminal nucleoprotein complexes in 162
the concerted integration pathway. 163 With in vitro assays that contain wt NY IN and a 1.6 kbp blunt-ended U5 LTR 164 substrate ( Fig. 1) , the synthesis of integration products proceeded in a time dependent 165 fashion, and was essentially complete after 2 h incubation at 37°C with a maximum FS 166 product production of 23% (Fig. 2B, lane 7) . It is possible to monitor the course of these 167 reactions by arresting enzymatic activities at various time points through the addition of 168 EDTA. These samples can then be either directly subjected to agarose gel 169 electrophoresis or first deproteinized and then subjected to electrophoresis, referred to 170
here as native and deproteinized samples, respectively ( Fig. 2A and Fig. 2B ). In the 171 former case at 15 to 45 min incubation at 37°C, the transient appearance of the SC 172 migrating at ~3.5 kbp was evident ( Fig. 1 and Fig. 2A ). It was shown through two-173 dimensional electrophoresis that the SC consists of free donor under non-covalent, IN-174 mediated juxtaposition (19). With further incubation, the SC disappeared upon 175 association with target DNA and underwent a conversion to the STC ( Fig. 2A, lanes 4 to 176 7), the terminal nucleoprotein product of concerted integration (16). Slower migrating 177
higher-order complexes of the SC, designated H-SC, and the STC are also evident (19). 178
Upon deproteinization, IN dissociated from the STC leaving the linear FS product (Fig.  179 2B) (16, 19, 20) . This implicates the SC as a precursor to the STC. 180
In addition to the intermediates and products in the concerted pathway, there are 181 products which result from side reactions arising from spurious nucleoprotein complexes 182 9 single donor end attacks one complement strand of the target (Fig. 1, Fig. 2A and 2B) . substrates. It is important to note that in the STC both DNA ends have undergone 3'-OH 195 processing and strand transfer, and our nomenclature here refers to the original identity of 196 the substrate. In order to resolve the possible FS products, we selected recessed (R) and 197 blunt-ended (B) 1.1 kbp and 1.6 kbp donor substrates, respectively. This scheme permits 198 the resolution of deproteinized products on a 1.5% agarose gel: B-B, B-R and R-R FS 199 products which necessarily arise from their respective B-B, B-R and R-R SC precursors 200 (Fig. 3) 
(19). 201
We carried out three reactions, the first containing 0.5 nM blunt 1.6 kbp substrate, 202 another containing 0.5 nM 1.1 kb recessed substrate, and a third containing 0.25 nM of 203 each (Fig. 3A, lanes 2 to 4) . All reactions contain 15 nM NY IN and were stopped 204 sequentially at 0, 20, 40, 60 and 120 min. The deproteinized samples were run on a 1.5% 205 agarose gel (Fig. 3A) . The formation of B-B FS product within the single blunt reaction 206 and 40 min at 37°C, and approaching saturation at 120 min (Fig. 3B ). In the single blunt 208 reaction, the final incorporation into FS product after 120 min incubation was 16 % (Fig.  209   3B ). Within the single recessed reaction (Fig. 3A, lanes 3, 6, 9 , 12, and 15) (Fig. 3B) and 210 in the mixed reaction (Fig. 3A, lanes 4, 7, 10 , 13, 16) (Fig. 3C) , the formation of R-R FS 211 product proceeds immediately, occurring much more rapidly than that of B-B FS product 212 (Fig. 3C ). In the reaction containing only recessed donor, the final incorporation into FS 213 product after 120 min is 8 % of all the products produced (Fig. 3B) . The formation of B-214 R FS product within the mixed reaction follows an intermediate course, appearing more 215 rapidly than the B-B FS product, but more slowly than the R-R FS product (Fig. 3A,  216 lanes 4, 7, 10, 13, 16) (Fig. 3C) . Ultimately, at 120 min, the quantities of the B-B and B-217 R FS product in the mixed reaction are nearly equivalent (Fig. 3C) . The identity of the B-218 B, B-R and R-R linear FS products from the mixed reactions were confirmed by two-219 dimensional electrophoresis (data not shown)(19). We repeated the mixed donor 220 experiment using a ratio of blunt to recessed donor of 1:1.5 and observed the same 221 ordering in rates of formation of the various possible FS products (data not shown). This 222
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indicates that the differential rates of formation do not arise solely from differences in 223 abundance of the various possible complexes. The results make several suggestions: 1. 224
The processing of DNA ends is the rate limiting step in the FS pathway. (Fig. 4) . The deproteinized samples 243 were run on a 1.5% agarose gel in order to facilitate the resolution of strand transfer 244 products as shown in Fig. 3A . The control reactions contained 0.5 nM blunt 1.6 kbp 245 substrate or 0.5 nM 1.1 kbp recessed substrate (Fig. 4A, lanes 3 and 4, respectively) . In 246 the blunt-ended control reaction after 120 min, incorporation into FS product reached 247 13.1%, while in the recessed control reaction it reached 5.8%. In the mixed control 248 reaction containing 0.25 nM each of blunt and recessed substrate with no L-870,810 (Fig.  249 4A, lane 5), the B-B, B-R and R-R incorporation into full-site products reached 3.0%, 250 3.1% and 2.1%, respectively, while the CHS products for the blunt and recessed reactions 251 Engaging the earlier described methodologies, we set out to determine the 276 catalytic properties and drug-resistance profiles of a set of these inhibitor-resistant IN 277 mutants associated with III-B strain of HIV-1 (10-12). We standardized our reactions 278 using wt, N155H, N155S and S153Y IN mutants with the 1.6 kbp U5 blunt end substrate, 279
analyzing strand transfer products on 0.7% agarose gels. We found that increasing the 280 incubation time from the standard 120 min to 240 min resulted in a marked increase in 281 the synthesis of FS products for N155H, N155S and S153Y but markedly less for wt IN 282 ( Fig. 5A and Fig. 5B ). The final incorporations into FS products after 240 min were 283 11.8%, 10.2%, 6.5%, and 4 % for wt, N155H, N155S and S153Y, respectively (Fig. 5C) . 284
SC and H-SC formation associated with N155S and S153Y were decreased and delayed 285 relative to that observed with wt and N155H on native agarose gels suggesting an 286 assembly defect with the blunt-ended substrate (data not shown). 287
To further illuminate the cause of the varying degrees of delayed synthesis, we 288 carried out an identical time-course experiment using the 1.1 kbp recessed substrate (Fig.  289   6A) . In all cases, the formation of FS product proceeded with greater rapidity relative to 290 reactions proceeding with blunt substrate with the maximum % incorporation into FS 291 product (Fig. 6B) . The maximum % incorporation after 240 min was 4.0%, 4.7%, 5.0%, 292 and 3.5% for wt, N155H, N155S, and S153Y, respectively (Fig. 6B) . It is important to 293 note that with the recessed substrate, the activities associated with incorporation into FS 294
and CHS products of all the enzymes are nearly equivalent. This suggests the existence 295 of a defect in 3'-OH processing in each mutant here analyzed, resulting in a delay rather 296 than an incapacitation thereof (Fig. 5) . 297 and inhibitor are summarized in Table 1 . The fold resistance or susceptibility to a given 311 inhibitor for each combination is summarized in graphical format (Fig. 7) . 312
The resistance profiles show that the N155S mutation is unique in its ability to 313 confer resistance to both NCA and DKA inhibitors. In all other cases here explored, a 314 mutation conferring resistance to one class of strand transfer inhibitor potentiates the 315 susceptibility to the other. It is important to note that the N155S mutation is not a 316 naturally occurring polymorphism (14) probably due to negative selection and is 317 therefore found less frequently in patients. associates rapidly with target, proceeding immediately to FS product (Fig. 3) . The B-B 326 SC forms a relatively long-lived, intermediate SC within which processing occurs 327 gradually (~16% of ends are processed in 20 min)(19) (Fig. 2 and Fig. 3) , and only upon 328 the ultimate processing of both blunt ends does the complex proceed to FS product. The 329 B-R SC proceeds to FS product with greater rapidity than the B-B SC but more slowly 330 than the R-R SC (Fig. 3) contains no inhibitor, resulted in the expected B-B, B-R, and R-R FS products (Fig. 4,  358 lane 5). Upon addition of increasing concentrations of L-870,810, there appeared a rapid 359 decline in the formation of all products arising from the blunt ended substrate, and 360 ineffective inhibition of R-R FS and R-CHS products arising from the recessed ended 361 substrate (Fig. 4A, lanes 6 to 12) . The potency of L-870,810 in its tendency to inhibit FS 362 product formation was as follows: B-B > B-R > R-R (Fig. 4B) . In our preliminary analyses of inhibitor-resistant N155H, N155S and S153Y III-B 379 IN mutants, it appeared that their activities were far insufficient to permit valid 380 evaluation, except for N155H which displayed ~60% of wt activities for FS and CHS 381 products after 120 min with blunt ended U5 substrate (Fig. 5) . For all mutants here 382 analyzed, incubation for 240 min at 37°C eventually resulted in progression to the STC 383 and a corresponding ~2 to 4-fold increase in the synthesis of FS product (Fig. 5C ). This 384 observation raises questions regarding the reason behind the delay in FS product 385 synthesis. Does the defect conferred by this set of mutations reside in 3'-OH processing, 386 strand transfer or both? To address this question we carried out a time course experiment 387 using a pre-processed substrate. For each mutant, we observed a marked augmentation in 388 the rapidity of FS product formation, with essential saturation in FS product formation 389
on November 12, 2017 by guest http://aac.asm.org/ Downloaded from after an additional 120 min incubation at 37°C (Fig. 6) . These results suggest indirectly 390 that the defect(s) conferred by the mutations reside both in assembly and likely in 391 processing using blunt-ended substrates, bringing about a delay rather than an 392 incapacitation thereof. We attempted to directly assess the 3' OH processing activity of 393 wt, N155H, N155S and S153Y IN by filling in a recessed substrate with 32 P-labelled 394 nucleotides, but found the results were difficult to interpret as a result of minor nuclease 395 contamination in the mutant IN preparations. that a resistance mutation might modify catalytic activity so as to circumvent the action 409 of the inhibitor in addition to reducing the affinity for the inhibitor. We showed in a 410 previous report that effective strand transfer inhibition requires the presence of blunt ends 411 within a wt SC and that strand transfer inhibitors recognize a transient structural 412
A C C E P T E D intermediate which arises before or during 3'-OH processing (19). Assuming that 413
inhibitor binding occurs during processing, which implies that the inhibitor should be in 414 association with complexes which have undergone 3'-OH processing and possess 415 recessed DNA ends, it seems reasonable that a delay in processing could give rise to lack 416 of inhibition. When an inhibitor-treated cell is infected with virus bearing a resistant IN 417 mutation, the PIC would be more likely, relative to wt virus, to retain blunt ends during 418 its traversing of the cytoplasm. In this state, assuming, for the sake of argument, that 419 binding of inhibitor requires the processing step, the PIC would remain unsusceptible to 420 the presence of inhibitor during its cytoplasmic voyage. When processing ultimately 421 occurred, after nuclear transport of the PIC, the resulting complex would be in the 422 vicinity of its genomic target, and could perhaps carry out concerted integration 423 We thank David Wirth, a rotating graduate student in our laboratory, for carrying 464 out the first combined blunt and recessed ended experiments. We also thank Patrick P. 465
Hecker for the design of 4, 7, 10, 13, 16 ). At the 593 top, the blunt ended and recessed donors are marked by the letters "B" and "R", 594 generated by averaging the % inhibition of FS product formation at a given concentration 652 of inhibitor, from at least three experiments, for each possible permutation of mutant and 653 inhibitor. Reaction conditions using blunt-ended donor and IN were described in Figure  654 3. For each independent experiment, % inhibition at a given concentration of inhibitor 655 was taken to be the percent decrease in FS product formation relative to reactions 656 containing no inhibitor. Best-fit non-linear, logistic, dose-response curves were 657 generated using Sigma Plot. 658 
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